Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer

BACKGROUND: Our previous study of pulmonary function in 34 patients with early breast cancer without preexisting lung disease showed that anthracycline- and taxane-based adjuvant dose-dense chemotherapy (DDC) caused a significant 16.4% mean reduction in carbon monoxide diffusing capacity (DLCO). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Landman, Yosef, Stemmer, Salomon Marcello, Sulkes, Aaron, Neiman, Victoria, Granot, Tal, Hendler, Daniel, Kramer, Mordechai Reuven, Gelmon, Karen, Yerushalmi, Rinat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854974/
https://www.ncbi.nlm.nih.gov/pubmed/31772578
http://dx.doi.org/10.1155/2019/2584859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854974/
https://www.ncbi.nlm.nih.gov/pubmed/31772578
http://dx.doi.org/10.1155/2019/2584859

Ejemplares similares